Skip to main content

STRS Ohio

SEC CIK
0000820478
Latest filing
Jul 30, 2026

VNDA holding history

Vanda Pharmaceuticals Inc. in every 13F filed by STRS Ohio, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VNDA overviewAll 13F holders of VNDAFull Q2 2026 holdings

Shares (Q2 2026)
85,100
Value
$520.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VNDA by STRS Ohio, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202685,100$520.8K<0.1%+15,400+22.1%AddedHolders
Q1 202669,700$481.6K<0.1%+69,400+23,133.3%AddedHolders
Q4 2025300$2.65K<0.1%00.0%UnchangedHolders
Q3 2025300$1.50K<0.1%00.0%UnchangedHolders
Q2 2025300$1.42K<0.1%00.0%UnchangedHolders
Q1 2025300$1.38K<0.1%−40,800−99.3%ReducedHolders
Q4 202441,100$196.9K<0.1%00.0%UnchangedHolders
Q3 202441,100$192.8K<0.1%00.0%UnchangedHolders
Q2 202441,100$232.2K<0.1%+4,200+11.4%AddedHolders
Q1 202436,900$151.0K<0.1%−21,100−36.4%ReducedHolders
Q4 202358,000$244.0K<0.1%00.0%UnchangedHolders
Q3 202358,000$250.0K<0.1%00.0%UnchangedHolders
Q2 202358,000$382.0K<0.1%+4,500+8.4%AddedHolders
Q1 202353,500$363.0K<0.1%00.0%UnchangedHolders
Q4 202253,500$395.0K<0.1%+7,900+17.3%AddedHolders
Q3 202245,600$450.0K<0.1%00.0%UnchangedHolders
Q2 202245,600$497.0K<0.1%+2,600+6.0%AddedHolders
Q1 202243,000$486.0K<0.1%+24,900+137.6%AddedHolders
Q4 202118,100$283.0K<0.1%−700−3.7%ReducedHolders
Q3 202118,800$322.0K<0.1%00.0%UnchangedHolders
Q2 202118,800$404.0K<0.1%+1,800+10.6%AddedHolders
Q1 202117,000$255.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.